Nicolas Pershaf
AssociatePractice areas:
Office:
Assistant:
Profile
I mainly assist Swedish and international companies with questions regarding intellectual property and procurement.
My daily work mainly involves regulatory issues in the areas of Life Sciences, procurement and competition law.
Språk: English, Swedish, Swedish
Karriär
2023-
Setterwalls
2023
Lund University
Case
Case | 03 Mar 2025
Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordination of price levels on generic drugs
Artiklar
News | 22 May 2026
The Swedish Dental and Pharmaceutical Benefits Agency proposes new regulations on applications for subsidies and the pricing of medicinal products
Läs nyhet
News | 22 May 2026
The Swedish Government is proposing new rules to enhance controls of fraud within the agri-food chain
Läs nyhet
News | 22 May 2026
Sweden’s application of the IPI measure in relation to Chinese medical devices: almost one year on
Läs nyhet
News | 23 Jun 2025
Withdrawal of the proposed Green Claims Directive by the European Commission
Läs nyhet
News | 22 May 2025
Significant fine upheld for unfair trading practices in the agricultural and food sector: A landmark case on the Swedish implementation of the UTP Directive
Läs nyhet
News | 24 Nov 2024
The European Court of Justice rules on the lawfulness of patent dispute settlement agreements under Article 101 TFEU
Läs nyhet
News | 09 Sep 2024
The Swedish and Danish Competition Authorities have carried out dawn raids at companies active in the pharmaceutical sector
Läs nyhet
News | 29 May 2024
Key takeaways for the environmental risk assessment (ERA) in the proposal for new EU pharmaceutical legislation
Läs nyhet
News | 30 Apr 2024
European Parliament adopts new directive on Corporate Sustainability Due Diligence – Three takeaways
Läs nyhet
News | 18 Dec 2023
The start of something bigger? First administrative fines based on the UTP Directive now imposed in Sweden
Läs nyhet
News | 06 Dec 2023
Proposal for new Directive and Regulation on medicinal products for human use
Läs nyhet